Evidence map›Paper›PMID 14982959›Full record

ArticleNucleic acids research2004

Homologous gene targeting in Caenorhabditis elegans by biolistic transformation.

Eugene Berezikov, Cornelia I Bargmann, Ronald H A Plasterk

Open access · bronzeAbstract read
In one paragraph

Article in Nucleic acids research, 2004. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 41 papers.

0numbers the graph read from it
0cells of the map it votes in
41citing papers in PubMed
1.7field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

41 citing papers in PubMed, 83 citations in OpenAlex.

  1. Article
  2. A Decade of CRISPR-Cas Gnome Editing inInternational journal of molecular sciences · 2022
    Review
  3. Animal Models to Study MicroRNA Function.Advances in cancer research · 2017
    Review
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Reverse genetics in eukaryotes.Biology of the cell · 2010
    Review
  17. Generation of transgenic C. elegans by biolistic transformation.Journal of visualized experiments : JoVE · 2010
    Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Eugene BerezikovHubrecht Laboratory, Netherlands Institute for Developmental Biology, Uppsalalaan 8, 3584 CT, Utrecht, The Netherlands.
Cornelia I Bargmann
Ronald H A Plasterk
Hubrecht Institute for Developmental Biology and Stem Cell Research · NL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Targeted homologous recombination is a powerful approach for genome manipulation that is widely used for gene alteration and knockouts in mouse and yeast. In Caenorhabditis elegans, several methods of target-selected mutagenesis have been implemented but none of them provides the opportunity of introducing exact predefined changes into the genome. Although anecdotal cases of homologous gene targeting in C.elegans have been reported, no practical technique of gene targeting has been developed so far. In this work we demonstrate that transformation of C.elegans by microparticle bombardment (biolistic transformation) can result in homologous recombination between introduced DNA and the chromosomal locus. We describe a scaled up version of biolistic transformation that can be used as a method for homologous gene targeting in the worm.

Indexed as

Sequence Homology, Nucleic AcidTransformation, GeneticAnimalsBiolisticsBlotting, SouthernCaenorhabditis elegansCaenorhabditis elegans ProteinsCalmodulin-Binding ProteinsGenes, HelminthGene TargetingMuscle ProteinsCaenorhabditis elegans ProteinsCalmodulin-Binding ProteinsMuscle Proteinsunc-22 protein, C elegans

Identifiers

PMID14982959
PMCPMC390312
OpenAlexW2163259891

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.